Although the atherosclerotic CV disease risk reduction and CKD progression benefits of SGLT-2 inhibitors may be found to be a class effect in future, the evidence for ertugliflozin (a third SGLT-2 inhibitor recently deleted from the market in Australia) is less robust with further studies ongoing
Ginkgo biloba plays a significant role in neuroplasticity by safeguarding mitochondrial integrity and mitigating glucocorticoid-induced dendritic atrophy (14)
Diabetes Manag
The Contrave vs Ozempic comparison highlights two distinct approaches to we Can Ozempic cause kidney stones
See more comments To view or add a comment, sign in More Relevant Posts An insightful commentary on Medscape today, What Beats the Biohacking Drug Metformin for Healthy Aging?, reinforces an important lesson: healthy aging is driven by comprehensive lifestyle interventions, not just medication
Bucholz EM, Rathore SS, Gosch K, Schoenfeld A, Jones PG, Buchanan DM, Spertus JA, Krumholz HM